---
layout: post
title: "Advisory Committee; Antimicrobial Drugs Advisory Committee; Renewal"
date: 2026-02-04 21:49:35 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-00357
original_published: 2025-01-10 00:00:00 +0000
significance: 8.00
---

# Advisory Committee; Antimicrobial Drugs Advisory Committee; Renewal

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** January 10, 2025 00:00 UTC
**Document Number:** 2025-00357

## Summary

The Food and Drug Administration (FDA or the Agency) is announcing the renewal of the Antimicrobial Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Antimicrobial Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the October 7, 2026, expiration date.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/01/10/2025-00357/advisory-committee-antimicrobial-drugs-advisory-committee-renewal)
- API: https://www.federalregister.gov/api/v1/documents/2025-00357

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
